Article Details
Retrieved on: 2024-03-31 10:59:17
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA clearance of the twiist automated insulin delivery system for type 1 diabetics, emphasizing precision delivery using the Tidepool Loop algorithm and the system's patient-centric design. Key companies like Sanofi and Medtronic are mentioned in context with diabetes care advancements, particularly concerning pregnancy-related endocrine management.
Article found on: www.technologyforyou.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here